Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Atara Biotherapeutics Q2 EPS $0.19 Beats $(0.81) Estimate, Sales $17.57M Beat $5.67M Estimate

Author: Benzinga Newsdesk | August 11, 2025 03:13pm
Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $(0.81) by 123.54 percent. This is a 106.13 percent increase over losses of $(3.10) per share from the same period last year. The company reported quarterly sales of $17.57 million which beat the analyst consensus estimate of $5.67 million by 210.15 percent. This is a 38.63 percent decrease over sales of $28.64 million the same period last year.

Posted In: ATRA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist